# Quality Control of CE-Certified Phonak Hearing Aids - 2018_07

> **NCT03555084** · NA · COMPLETED · sponsor: **Sonova AG** · enrollment: 16 (actual)

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DEVICE:** Extension of Virto B-Titanium
- **DEVICE:** Virto B-Titanium

## Key facts

- **NCT ID:** NCT03555084
- **Lead sponsor:** Sonova AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-22
- **Primary completion:** 2018-06-22
- **Final completion:** 2018-06-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03555084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03555084, "Quality Control of CE-Certified Phonak Hearing Aids - 2018_07". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03555084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*